93 related articles for article (PubMed ID: 7843645)
1. Effects of recombinant hirudin on D dimer levels before and after experimental venous thrombosis.
Monreal M; Angles AM; Monreal L; Roncales J; Monasterio J
Haemostasis; 1994; 24(6):338-43. PubMed ID: 7843645
[TBL] [Abstract][Full Text] [Related]
2. Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery.
Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
Thromb Haemost; 1997 Feb; 77(2):267-9. PubMed ID: 9157579
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human ex vivo model of arterial thrombosis.
Bossavy JP; Sakariassen KS; Rübsamen K; Thalamas C; Boneu B; Cadroy Y
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1348-53. PubMed ID: 10323789
[TBL] [Abstract][Full Text] [Related]
4. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
[TBL] [Abstract][Full Text] [Related]
6. Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin.
Agnelli G; Renga C; Weitz JI; Nenci GG; Hirsh J
Blood; 1992 Aug; 80(4):960-5. PubMed ID: 1498336
[TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant hirudin (r-hirudin, HBW 023) on coagulation and platelet activation in vivo. Comparison with unfractionated heparin and a low-molecular-weight heparin preparation (fragmin).
Eichinger S; Wolzt M; Schneider B; Nieszpaur-Los M; Heinrichs H; Lechner K; Eichler HG; Kyrle PA
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):886-92. PubMed ID: 7600120
[TBL] [Abstract][Full Text] [Related]
8. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
9. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits.
Agnelli G; Pascucci C; Cosmi B; Nenci GG
Thromb Haemost; 1990 Apr; 63(2):204-7. PubMed ID: 2363121
[TBL] [Abstract][Full Text] [Related]
10. Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy.
Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
Blood Coagul Fibrinolysis; 1995 Feb; 6(1):60-4. PubMed ID: 7540878
[TBL] [Abstract][Full Text] [Related]
11. Prothrombin fragment 1 + 2, thrombin-antithrombin III complexes and D-dimers in acute deep vein thrombosis: effects of heparin treatment.
Estivals M; Pelzer H; Sie P; Pichon J; Boccalon H; Boneu B
Br J Haematol; 1991 Jul; 78(3):421-4. PubMed ID: 1873225
[TBL] [Abstract][Full Text] [Related]
12. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic significance of thrombin-antithrombin III complex (TAT) and D-dimer in patients with deep venous thrombosis.
Sassa H; Sone T; Tsuboi H; Kondo J; Yabashi T
Jpn Circ J; 1996 Apr; 60(4):201-6. PubMed ID: 8726168
[TBL] [Abstract][Full Text] [Related]
14. Comparison of thrombin-antithrombin complex (TAT) levels and fibrinopeptide A following thrombin incubation of human plasma using hirudin as an inhibitor of TAT formation.
Haaland AK; Skjønsberg OH; Gravem K; Ruyter R; Godal HC
Thromb Res; 1991 Feb; 61(3):253-9. PubMed ID: 2028444
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of recombinant hirudin and standard heparin in the Wessler model.
Bara L; Bloch MF; Samama MM
Thromb Res; 1992 Oct; 68(2):167-74. PubMed ID: 1475779
[TBL] [Abstract][Full Text] [Related]
16. Hirudin interruption of heparin-resistant arterial thrombus formation in baboons.
Kelly AB; Marzec UM; Krupski W; Bass A; Cadroy Y; Hanson SR; Harker LA
Blood; 1991 Mar; 77(5):1006-12. PubMed ID: 1995089
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic potency of hirudin is increased in nonhuman primates by fibrin targeting.
Bode C; Hanson SR; Schmedtje JF; Haber E; Mehwald P; Kelly AB; Harker LA; Runge MS
Circulation; 1997 Feb; 95(4):800-4. PubMed ID: 9054733
[TBL] [Abstract][Full Text] [Related]
18. Comparative study on the antithrombotic efficacy of hirudin, heparin and a low-molecular weight heparin in preventing experimentally induced venous thrombosis.
Monreal M; Galego G; Monreal L; Angles AM; Monasterio J; Oller B
Haemostasis; 1993; 23(3):179-83. PubMed ID: 8276322
[TBL] [Abstract][Full Text] [Related]
19. The coagulofibrinolytic state of patients with primary varicose veins of the lower legs.
Ikeda M; Kambayashi J; Iwamoto S; Shinoki N; Nakamura T; Shibuya T; Kawasaki T; Monden M
Surg Today; 1996; 26(12):985-9. PubMed ID: 9017960
[TBL] [Abstract][Full Text] [Related]
20. [Laboratory diagnosis of left atrial thrombi in patients with mitral stenosis].
Hayashi I
Fukuoka Igaku Zasshi; 1991 Nov; 82(11):550-61. PubMed ID: 1774012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]